Log in
Sign up
Golden has been acquired by ComplyAdvantage.Read about it here ⟶
‌

US Patent 11919903 Polymorphs

OverviewStructured DataIssuesContributorsActivity
Is a
Patent
Patent
0
Date Filed
June 30, 2021
0
Date of Patent
March 5, 2024
0
Patent Application Number
17363441
0
Patent Citations
‌
US Patent 9212183 Salt forms of 1-[(4-methyl-quinazolin-2-yl)methyl]-3-methyl-7-(2-butyn-1-yl)-8-(3-(R)-amino-piperidin-1-yl)-xanthine
0
‌
US Patent 9493462 Polymorphs
0
‌
US Patent 9815837 Polymorphs
0
‌
US Patent 10023574 8-[3-amino-piperidin-1-yl]-xanthines, the preparation thereof and their use as pharmaceutical compositions
0
‌
US Patent 10034877 Treatment for diabetes in patients inappropriate for metformin therapy
0
‌
US Patent 10092571 Treatment of genotyped diabetic patients with DPP-IV inhibitors such as linagliptin
0
‌
US Patent 10155000 Medical use of pharmaceutical combination or composition
0
‌
US Patent 8399414 Analgesics
0
‌
US Patent 10301313 Polymorphs
0
‌
US Patent 10973827 DPP-IV inhibitor combined with a further antidiabetic agent, tablets comprising such formulations, their use and process for their preparation
0
•••
Patent Inventor Names
Thomas Nicola
0
Dirk Kemmer
0
Martin Renz
0
Peter Sieger
0
Peter Kohlbauer
0
Patent Jurisdiction
United States Patent and Trademark Office
United States Patent and Trademark Office
0
Patent Number
11919903
0
Patent Primary Examiner
‌
John S Kenyon
0
CPC Code
‌
C07B 2200/13
0
‌
C07D 473/06
0
‌
C07D 473/04
0

Find more entities like US Patent 11919903 Polymorphs

Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
Open Query Tool
Access by API
Golden Query Tool
Golden logo